The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis

L Makowski, GS Hotamisligil - Current opinion in lipidology, 2005 - journals.lww.com
Current opinion in lipidology, 2005journals.lww.com
Adipocyte/macrophage fatty acid binding proteins, aP2 and mal1, act at the interface of
metabolic and inflammatory pathways. These fatty acid binding proteins are involved in the
formation of atherosclerosis predominantly through the direct modification of macrophage
cholesterol trafficking and inflammatory responses. In addition to atherosclerosis, these fatty
acid binding proteins also exert a dramatic impact on obesity, insulin resistance, type 2
diabetes and fatty liver disease. The creation of pharmacological agents to modify fatty acid …
Summary
Adipocyte/macrophage fatty acid binding proteins, aP2 and mal1, act at the interface of metabolic and inflammatory pathways. These fatty acid binding proteins are involved in the formation of atherosclerosis predominantly through the direct modification of macrophage cholesterol trafficking and inflammatory responses. In addition to atherosclerosis, these fatty acid binding proteins also exert a dramatic impact on obesity, insulin resistance, type 2 diabetes and fatty liver disease. The creation of pharmacological agents to modify fatty acid binding protein function will provide tissue or cell-type-specific control of these lipid signaling pathways, inflammatory responses, atherosclerosis, and the other components of the metabolic syndrome, therefore offering a new class of multi-indication therapeutic agents.
Lippincott Williams & Wilkins